Post-approval studies (Phase 4)Not Yet RecruitingNCT07683975
What this trial is testing
Infliximab for Immune Checkpoint Inhibitor Associated AKI
Who this might be right for
Acute Kidney InjuryAcute Interstitial Nephritis
Massachusetts General Hospital 44